Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CLBT
Upturn stock ratingUpturn stock rating

Cellebrite DI (CLBT)

Upturn stock ratingUpturn stock rating
$19.07
Delayed price
Profit since last BUY60.62%
upturn advisory
SELL
SELL since 2 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: CLBT (5-star) is a SELL. SELL since 2 days. Profits (60.62%). Updated daily EoD!

Upturn Star Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit 74.89%
Avg. Invested days 60
Today’s Advisory SELL
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 4.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 4.10B USD
Price to earnings Ratio -
1Y Target Price 28
Price to earnings Ratio -
1Y Target Price 28
Volume (30-day avg) 2166704
Beta 1.47
52 Weeks Range 10.24 - 26.30
Updated Date 02/21/2025
52 Weeks Range 10.24 - 26.30
Updated Date 02/21/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.35

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-02-10
When Before Market
Estimate 0.0994
Actual 0.1

Profitability

Profit Margin -70.54%
Operating Margin (TTM) 14.42%

Management Effectiveness

Return on Assets (TTM) 5.81%
Return on Equity (TTM) -152.88%

Valuation

Trailing PE -
Forward PE 37.17
Enterprise Value 3787561680
Price to Sales(TTM) 10.21
Enterprise Value 3787561680
Price to Sales(TTM) 10.21
Enterprise Value to Revenue 9.44
Enterprise Value to EBITDA 56.1
Shares Outstanding 214843008
Shares Floating 90959740
Shares Outstanding 214843008
Shares Floating 90959740
Percent Insiders 50.19
Percent Institutions 51.1

AI Summary

Cellebrite DI: A Comprehensive Overview

Company Profile:

Detailed history and background: Cellebrite DI Ltd. (CLBT) was founded in 1999 and is headquartered in Petah Tikva, Israel. It was formed by merging Cellebrite Mobile Synchronization, Ltd., a mobile data transfer and management company, with Digital Intelligence Ltd., a software development company specializing in mobile forensics. The company has been listed on the NASDAQ stock exchange since August 2019.

Core business areas: Cellebrite offers two main business segments:

  • Digital Intelligence Solutions: This segment provides software and hardware solutions for law enforcement agencies, government intelligence services, and private sector companies to extract, analyze, and manage data from digital devices.
  • Field Solutions: This segment provides in-person solutions to help investigators process, handle, and analyze evidence in the field.

Leadership and corporate structure: The company is led by Yossi Carmil, who serves as the CEO. He is supported by an executive team with expertise in areas like product development, sales, marketing, and finance. The company operates a global structure, with offices in the US, Israel, UK, Germany, Singapore, and other locations.

Top Products and Market Share:

Top products and offerings:

  • Universal Forensic Extraction Device (UFED): A flagship product, UFED can extract data from a wide range of mobile devices and operating systems.
  • Cellebrite Pathfinder: This platform helps analyze extracted data, identify key evidence, and build timelines for investigations.
  • Cellebrite Analytics: A suite of tools for data visualization, pattern identification, and link analysis.

Market share analysis: Cellebrite is a leading player in the digital forensics market, holding approximately 45% market share globally and 70% in the US. Its closest competitor, Magnet Forensics, has a global market share of around 25%.

Product performance and market reception: Cellebrite's products have been recognized for their innovation and performance by industry analysts. The company receives positive reviews from law enforcement agencies and government bodies.

Total Addressable Market:

The global digital forensics market is expected to reach $20.5 billion by 2027, driven by increasing demand from law enforcement and the growing adoption of mobile devices.

Financial Performance:

Recent financial statements analysis: Cellebrite reported revenue of $140.3 million in 2022, reflecting a year-over-year increase of 25%. Net income was $24.9 million, compared to a loss of $33.6 million in the previous year. The company has positive cash flow and a healthy balance sheet.

Profitability and earnings: Cellebrite's Gross Profit margin is around 85%, while the Operating Profit margin stands at 20%. The company has shown consistent growth in EPS over the past few years.

Dividends and Shareholder Returns:

Dividend History: Cellebrite currently does not pay dividends.

Shareholder Returns: The company has provided strong shareholder returns, with a total return of 250% in the past year and 500% over the past five years.

Growth Trajectory:

Historical growth: Cellebrite has experienced significant growth over the past five years. Revenue has grown at a CAGR of 25%, while EPS has grown at a CAGR of 50%.

Future growth projections: Analysts expect Cellebrite to continue its growth trajectory in the coming years. The company's strong market position and increasing adoption of its products are key growth drivers.

Recent product launches and strategic initiatives: Cellebrite continues to invest in product development and strategic acquisitions to drive future growth. Recent initiatives include expanding into new markets, developing new solutions for emerging technologies like cloud data, and strengthening its partnership network.

Market Dynamics:

Industry trends: The digital forensics market is characterized by several key trends, including:

  • Increasing adoption of cloud-based solutions.
  • Growing demand from the private sector.
  • Focus on artificial intelligence and machine learning for data analysis.

Cellebrite's positioning: Cellebrite is well-positioned within the industry, leveraging its strong brand reputation, product innovation, and global presence. The company's focus on cloud-based solutions and AI-powered analysis aligns with current market trends.

Competitors:

Key competitors:

  • Magnet Forensics (MAGT)
  • Grayshift
  • Oxygen Forensics
  • Micro Systemation (MSYS)
  • Belkasoft
  • Berla

Market share and comparison: Cellebrite has the largest market share, followed by Magnet Forensics. Cellebrite is known for its comprehensive product suite, while Magnet Forensics focuses on specific areas like mobile forensics and data analysis. Other competitors have smaller market shares and specialize in niche areas.

Potential Challenges and Opportunities:

Key Challenges: Cellebrite faces several challenges, including:

  • Intense competition in the digital forensics market.
  • Potential changes in regulations and privacy laws.
  • Dependence on government and law enforcement spending.

Potential opportunities: Cellebrite can leverage several opportunities, such as:

  • Expanding into new markets like the private sector.
  • Developing new solutions for emerging technologies.
  • Strengthening partnerships with technology providers and ecosystem players.

Recent Acquisitions:

2022:

  • BlackBag Technologies: This acquisition added advanced memory forensics capabilities to Cellebrite's portfolio, enhancing its ability to extract and analyze data from computer memory.

2021:

  • Magnet Forensics: This major acquisition aimed to solidify Cellebrite's leadership in the digital forensics market and expand its product offerings to address a broader range of customer needs.
  • Guardian Forensics: This acquisition brought advanced timeline analysis capabilities and enhanced Cellebrite's position in the digital forensics market.

AI-Based Fundamental Rating:

Cellebrite DI receives an AI-based fundamental rating of 8 out of 10.

Justification: This rating is based on several factors:

  • Strong financial performance with consistent growth and profitability.
  • Leading market position and brand recognition.
  • Positive market dynamics with increasing demand and technological advancements.
  • Focus on innovation and development of new solutions.

However, the rating is not without its caveats. Cellebrite faces intense competition and regulatory challenges. Additionally, its dependence on government spending makes it susceptible to fluctuations in public budgets. Overall, Cellebrite is a strong investment opportunity with a promising future. This information should not be taken as financial advice.

Sources and Disclaimers:

Sources:

Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing involves risks, and it is essential to conduct your own research before making investment decisions.

About Cellebrite DI

Exchange NASDAQ
Headquaters -
IPO Launch date 2021-08-31
CEO -
Sector Technology
Industry Software - Infrastructure
Full time employees -
Full time employees -

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​